Biogen Idec Inc. (NASDAQ:BIIB) – Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors

[at noodls] – WALTHAM, Mass., Nov. 19, 2013 (GLOBE NEWSWIRE) — Repligen Corporation today announced that it has elected to its Board of Directors John G. Cox, Executive Vice President of Pharmaceutical Operations . . . → Read More: Biogen Idec Inc. (NASDAQ:BIIB) – Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors Similar posts: Biogen Idec Inc. (NASDAQ:BIIB) | Better Buy: Biogen or Amgen? Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies